Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Acute Myeloid Leukemia or Myelodysplastic Syndrome in Randomized Controlled Clinical Trials of Cancer Chemotherapy With Granulocyte Colony-Stimulating Factor: A Systematic Review
2010
The CYP3A4*1B variant is related to the onset of puberty, a known risk factor for the development of breast cancer.
2003
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
2007
Facts and Controversies in Systemic Treatment of Metastatic Breast Cancer
2004
Pegylated Liposomal Doxorubicin and Trastuzumab in HER-2 Overexpressing Metastatic Breast Cancer: A Multicenter Phase II Trial
2006
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Endogenous Estrogen, Androgen, and Progesterone Concentrations and Breast Cancer Risk Among Postmenopausal Women
2004
A Meta-analysis of Body Mass Index and Risk of Premenopausal Breast Cancer
1995
Mucin-Type Glycoproteins
1992
Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)
2003
Breast cancer
2016 Standout
Protein nanoparticles as drug carriers in clinical medicine
2008
A Longitudinal Assessment of Hormonal and Physical Alterations during Normal Puberty in Boys. V. Rising Leptin Levels May Signal the Onset of Puberty1
1997
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Surface Charge Switchable Nanoparticles Based on Zwitterionic Polymer for Enhanced Drug Delivery to Tumor
2012
Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast Cancer
1999
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
1995 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study
2004
Childhood obesity: public-health crisis, common sense cure
2002 Standout
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
2005 Standout
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Central obesity and breast cancer risk: a systematic review
2003
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Maternal and child undernutrition: consequences for adult health and human capital
2008 Standout
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Pharmacokinetics of Pegylated Liposomal Doxorubicin
2003
The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer
1988
A Meta-Analysis of Published Literature on Waist-to-Hip Ratio and Risk of Breast Cancer
2002
Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991
1994 Standout
Individual patient data analysis to assess modifications to the RECIST criteria
2008
Obesity and prognosis of breast cancer
2006
Impact of timing of pubertal maturation on growth in black and white female adolescents: The National Heart, Lung, and Blood Institute Growth and Health Study
2001
Epithelial Mucin Genes
1995
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Risk for and consequences of endometriosis: A critical epidemiologic review
2018
A 12-Item Short-Form Health Survey
1996 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Does the intake of nuts and seeds alter the appearance of menarche?
1995
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
2006
Evaluating Translations of Health Status Questionnaires: Methods From the IQOLA Project
1995
Obesity as a medical problem
2000 StandoutNature
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
The duration of puberty in girls is related to the timing of its onset
1997
Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
2005
Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer
2008
Mucin Granule Intraluminal Organization in Living Mucous/Goblet Cells
2005 StandoutNobel
Exposures in Childhood, Adolescence and Early Adulthood and Breast Cancer Risk: a Systematic Review of the Literature
2003
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
1998 StandoutNature
Synthetic glycopeptides and glycoproteins as tools for biology
2004 StandoutNobel
Plasma Sex Steroid Hormone Levels and Risk of Breast Cancer in Postmenopausal Women
1998
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
A new class of membrane-bound chemokine with a CX3C motif
1997 StandoutNature
Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States)
1998
Detection of anthracycline-induced cardiotoxicity
1999
Leptin and the regulation of body weight in mammals
1998 StandoutNature
MUC1 and the MUCs: A Family of Human Mucins with Impact in Cancer Biology
2004
Pooled Analysis of Prospective Cohort Studies on Height, Weight, and Breast Cancer Risk
2000
Puberty begins with a characteristic subcutaneous body fat mass in each sex
2000
Identifying Patients at High Risk for Neutropenic Complications During Chemotherapy for Metastatic Breast Cancer With Doxorubicin or Pegylated Liposomal Doxorubicin
2008
Serum Hormones and the Alcohol-Breast Cancer Association in Postmenopausal Women
2001
A Review of the Association between Abdominal Fat Distribution, Health Outcome Measures, and Modifiable Risk Factors
1993
Biomimetic Engineering of Carbon Nanotubes by Using Cell Surface Mucin Mimics
2004 StandoutNobel
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
Nutrition and endometrial cancer
1996
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Hierarchical Assembly of Model Cell Surfaces: Synthesis of Mucin Mimetic Polymers and Their Display on Supported Bilayers
2007 StandoutNobel
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Control of the Molecular Orientation of Membrane-Anchored Biomimetic Glycopolymers
2009 StandoutNobel
Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer
2009
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies
2011 Standout
Earlier Onset of Puberty in Girls: Relation to Increased Body Mass Index and Race
2001
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
2002
Are Increased Plasma Non-Esterified Fatty Acid Concentrations a Risk Marker for Coronary Heart Disease and other Chronic Diseases?
1996
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
2006
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
General and Abdominal Obesity and Survival among Young Women with Breast Cancer
2006
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Visceral fat in prepubertal children: Influence of obesity, anthropometry, ethnicity, gender, diet, and growth
1999
Obesity as a risk factor for certain types of cancer
1998
Homogeneous Glycopeptides and Glycoproteins for Biological Investigation
2002 StandoutNobel
Early Change in Patient-Reported Health During Lung Cancer Chemotherapy Predicts Clinical Outcomes Beyond Those Predicted by Baseline Report: Results From Eastern Cooperative Oncology Group Study 5592
2003
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Chemoselective Elaboration of O-Linked Glycopeptide Mimetics by Alkylation of 3-ThioGalNAc
2001 StandoutNobel
Extending Survival with Chemotherapy in Metastatic Breast Cancer
2005
Endometriosis
2020 Standout
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial
2003
Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer
2005
Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies
2002 Standout
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
Endometriosis
2018
Adolescence: a foundation for future health
2012 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal Women
2003
Percent Body Fat at Age 5 Predicts Earlier Pubertal Development Among Girls at Age 9
2003
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Rapid Maturation of the Reproductive Axis during Perimenarche Independent of Body Composition1
2000
Is Obesity Associated With Early Sexual Maturation? A Comparison of the Association in American Boys Versus Girls
2002
Maturational timing and overweight prevalence in US adolescent girls
2001
CNS Metastases in Breast Cancer
2004
Works of P.F. Bruning being referenced
Body fat mass, body fat distribution, and pubertal development: a longitudinal study of physical and hormonal sexual maturation of girls.
1992
Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer
2000
Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer
1989
Endogenous estrogens and breast cancer a possible relationship between body fat distribution and estrogen availability
1987
The quality of life of long-term survivors of Hodgkin's disease
1994
Paclitaxel Versus Doxorubicin as First-Line Single-Agent Chemotherapy for Metastatic Breast Cancer: A European Organization for Research and Treatment of Cancer Randomized Study With Cross-Over
2000
Relation of Serum Levels of Testosterone and Dehydroepiandrosterone Sulfate to Risk of Breast Cancer in Postmenopausal Women
1997
Body Fat Mass, Body Fat Distribution, and Plasma Hormones in Early Puberty in Females
1990
EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer
2002
Assessment of anthracycline-related myocardial adrenergic derangement by [123i]metaiodobenzylguanidine scintigraphy
1995
A Study of the Value of p53, HER2, and Bcl-2 in the Prediction of Response to Doxorubicin and Paclitaxel as Single Agents in Metastatic Breast Cancer: A Companion Study to EORTC 10923
2000
The binding of blood‐borne estrogens in normal vegetarian and omnivorous women and the risk of breast cancer
1988
Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter Study
2003
Body measurements, estrogen availability and the risk of human breast cancer: A case‐control study
1992
MAM-6 antigen, a new serum marker for breast cancer monitoring.
1986
Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial
2002
Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk
1985
Response of leptomeningeal metastases from breast cancer to hormonal therapy
2000
Factors influencing waist/hip ratio in randomly selected pre- and post-menopausal women in the dom-project (preliminary results).
1989